Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amit Misra

Showing results (91-100 of 102) with videos related to

Pageof 11
Sort By:
Antimicrobial Agents and Chemotherapy|November 28, 2012
Inhaled microparticles containing clofazimine are efficacious in treatment of experimental tuberculosis in miceRahul Kumar Verma, Willem A Germishuizen, M Portia Motheo, et al.
Tuberculosis (Edinburgh, Scotland)|July 8, 2024
Macrophage-targeted versus free calcitriol as host-directed adjunct therapy against Mycobacterium tuberculosis infection in mice is bacteriostatic and mitigates tissue pathologyD V Siva Reddy, Hasham Shafi Sofi, Trisha Roy, et al.
Journal of Hazardous Materials|June 8, 2025
Metabolic dysregulation and temporal dynamics of NF-κB-p65/NLRP3, TXNIP, endoplasmic reticulum and mitochondrial stress in silica-induced pulmonary fibrosis in ratsKaveri R Washimkar, Chirag Kulkarni, Manendra Singh Tomar, et al.
Tuberculosis (Edinburgh, Scotland)|July 26, 2011
Open source drug discovery--a new paradigm of collaborative research in tuberculosis drug developmentAnshu Bhardwaj, Vinod Scaria, Gajendra Pal Singh Raghava, et al.
AAPS Pharmscitech|June 8, 2023
Inhaled Adjunct Therapy with Second-Line Drug Candidates for Dose Reduction in Chemotherapeutic Regimens for Multi-drug-Resistant TuberculosisSonia Verma, Nils-Jorgen K Dal, Ashish Srivastava, et al.
Tuberculosis (Edinburgh, Scotland)|March 15, 2025
Dry powder Inhalation of lytic mycobacteriophages for adjunct therapy in a mouse model of infection with MycobacteriumtuberculosisSunil K Raman, Trisha Roy, Khushboo Verma, et al.
Tuberculosis (Edinburgh, Scotland)|April 29, 2021
Inhalable particles containing isoniazid and rifabutin as adjunct therapy for safe, efficacious and relapse-free cure of experimental animal tuberculosis in one monthAmit K Singh, Rahul K Verma, Jatinder Kaur Mukker, et al.
Scientific Reports|December 14, 2020
Large global variations in measured airborne metal concentrations driven by anthropogenic sourcesJacob McNeill, Graydon Snider, Crystal L Weagle, et al.
Environmental Science & Technology|September 15, 2018
Global Sources of Fine Particulate Matter: Interpretation of PMCrystal L Weagle, Graydon Snider, Chi Li, et al.
Plos Biology|February 19, 2005
Discovery-based science education: functional genomic dissection in Drosophila by undergraduate researchersJiong Chen, Gerald B Call, Elsa Beyer, et al.
Pageof 11

Showing results (91-100 of 102) with videos related to

Sort By:
Pageof 11
Antimicrobial Agents and Chemotherapy|November 28, 2012
Inhaled microparticles containing clofazimine are efficacious in treatment of experimental tuberculosis in miceRahul Kumar Verma, Willem A Germishuizen, M Portia Motheo, et al.
Tuberculosis (Edinburgh, Scotland)|July 8, 2024
Macrophage-targeted versus free calcitriol as host-directed adjunct therapy against Mycobacterium tuberculosis infection in mice is bacteriostatic and mitigates tissue pathologyD V Siva Reddy, Hasham Shafi Sofi, Trisha Roy, et al.
Journal of Hazardous Materials|June 8, 2025
Metabolic dysregulation and temporal dynamics of NF-κB-p65/NLRP3, TXNIP, endoplasmic reticulum and mitochondrial stress in silica-induced pulmonary fibrosis in ratsKaveri R Washimkar, Chirag Kulkarni, Manendra Singh Tomar, et al.
Tuberculosis (Edinburgh, Scotland)|July 26, 2011
Open source drug discovery--a new paradigm of collaborative research in tuberculosis drug developmentAnshu Bhardwaj, Vinod Scaria, Gajendra Pal Singh Raghava, et al.
AAPS Pharmscitech|June 8, 2023
Inhaled Adjunct Therapy with Second-Line Drug Candidates for Dose Reduction in Chemotherapeutic Regimens for Multi-drug-Resistant TuberculosisSonia Verma, Nils-Jorgen K Dal, Ashish Srivastava, et al.
Tuberculosis (Edinburgh, Scotland)|March 15, 2025
Dry powder Inhalation of lytic mycobacteriophages for adjunct therapy in a mouse model of infection with MycobacteriumtuberculosisSunil K Raman, Trisha Roy, Khushboo Verma, et al.
Tuberculosis (Edinburgh, Scotland)|April 29, 2021
Inhalable particles containing isoniazid and rifabutin as adjunct therapy for safe, efficacious and relapse-free cure of experimental animal tuberculosis in one monthAmit K Singh, Rahul K Verma, Jatinder Kaur Mukker, et al.
Scientific Reports|December 14, 2020
Large global variations in measured airborne metal concentrations driven by anthropogenic sourcesJacob McNeill, Graydon Snider, Crystal L Weagle, et al.
Environmental Science & Technology|September 15, 2018
Global Sources of Fine Particulate Matter: Interpretation of PMCrystal L Weagle, Graydon Snider, Chi Li, et al.
Plos Biology|February 19, 2005
Discovery-based science education: functional genomic dissection in Drosophila by undergraduate researchersJiong Chen, Gerald B Call, Elsa Beyer, et al.
Pageof 11